(Q37527099)

20 August 2017

title

Antiretroviral therapy for treatment-naïve patients: a review of recent literature and the updated guidelines (English)

1 reference

20 August 2017

main subject

anti-retroviral agent

0 references

2

Paul E Sax

1 reference

20 August 2017

Jennifer A Johnson

1

1 reference

20 August 2017

language of work or name

1 reference

1 July 2009

1 reference

Current infectious disease reports

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

311-318

1 reference

Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-009-0046-Y

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults

21 January 2018

1 reference

12 December 2020

Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults

1 reference

12 December 2020

Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine

1 reference

12 December 2020

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

1 reference

12 December 2020

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

12 December 2020

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

1 reference

12 December 2020

Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir

1 reference

12 December 2020

A comparison of three initial antiretroviral AIDS regimens

1 reference

12 December 2020

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

1 reference

12 December 2020

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

12 December 2020

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

12 December 2020

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects

1 reference

12 December 2020

Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.

1 reference

12 December 2020

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

1 reference

12 December 2020

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

1 reference

12 December 2020

Changes in the risk of death after HIV seroconversion compared with mortality in the general population

1 reference

12 December 2020

Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System

1 reference

12 December 2020

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

1 reference

12 December 2020

Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen.

1 reference

12 December 2020

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

1 reference

12 December 2020

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

12 December 2020

Efficacy and safety of once-daily regimens in the treatment of HIV infection

1 reference

12 December 2020

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

1 reference

12 December 2020

10.1007/S11908-009-0046-Y

Identifiers

DOI

1 reference

20 August 2017

1 reference